1. Introduction
Estrogen not only plays an essential role in the luteinizing hormone peak during the periconceptional period, but is also involved in placentation through remodeling the function of immune cells and the expression of angiogenic factors in the uterus during early pregnancy [
1]. Estrogen mediates the process of implantation through regulating the expression of estrogen-modulated paracrine factors in the uterus, and these factors can promote cell growth, or amplify estrogenic effects during early pregnancy [
2]. Estrogen can induce vasodilator production via estrogen receptors (ERs), including ERα and ERβ, in the uterine artery, which is necessary in providing nutrient support for fetal growth and survival during pregnancy in humans [
3]. The expression of ERα and ERβ in the endometrium is necessary for normal pregnancy, and ERα is related to uterine cell proliferation, but ERβ has a negative effect on ERα action [
4]. A high level of estrogen enhances the proportions of CD4
+ CD25
+ Treg in peripheral blood, which is essential for estrogen-mediated immunomodulation during pregnancy in humans [
5].
There is a dynamic adaptation in the maternal immune system during pregnancy, which contributes to a tolerance towards the allogeneic fetus, but not a broad maternal immune inhibition [
6]. Estrogens secreted from the ovary and placenta can modulate the immune system development and immune responses via its receptors expressed in the immune cells, which is involved in the adaptation of the organism to the intrinsic physiological changes in females [
7]. Estrogen can suppress autophagy of the immune system via ERα and ERβ, which plays a key role in pre-implantation and maintaining embryo survival [
8]. In addition, estrogens have effects on innate and adaptive immunity, which modulate the activity of different immune cells in the thymus, spleen, and lymph node through ERα and ERβ [
9].
In ruminants, conceptus signal (interferon-tau, IFNT) and high levels of progesterone modulate the maternal innate immune system, which changes immune function both locally and systemically during pregnancy [
10]. IFNT has paracrine and endocrine actions in modulating maternal innate immune functions, which is essential for avoiding conceptus rejection by the mother during early pregnancy in ruminants [
11]. Our previous studies report that IFNT has effects on bone marrow, thymus, spleen, lymph nodes, and liver through an endocrine manner during early pregnancy in ewes. In sheep, early pregnancy has effects on the expression of melatonin receptors, gonadotropin-releasing hormone and its receptor, and prolactin and its receptor in the ovine thymus, lymph node, spleen, and liver [
12], which modulates the function of the maternal immune system via endocrine and/or paracrine/autocrine pathways in a tissue-specific manner. However, it is not clear if early pregnancy has effects on the expression of ERα and ERβ in the maternal thymus, lymph node, spleen, and liver. The aim of the present study was to investigate the expression of ERα and ERβ in these organs from nonpregnant ewes and early pregnant ewes, which will contribute to understanding pregnancy immune tolerance.
4. Discussion
The thymus is responsible for the generation of a T-cell receptor repertoire, which responds to foreign antigens, provides surveillance, and remains tolerant to self [
14]. Pregnancy induces a severe reduction in thymus size and thymocyte output, which is associated with the suppression of chemokines in the thymic nonlymphoid cells during pregnancy [
15]. Our previous studies report that the immune signaling pathways, including complement pathway, nod-like receptor pathway, nod-like receptor pathway, and toll-like receptor pathway, as well as kappa B subunits and IkappaB protein, are changed in the maternal thymus [
16], which is involved in the maternal immune regulation in sheep. Estrogens regulate the expression of Aire via ERs, which modulates the expression of tissue-restricted antigen genes to generate self-peptides to bind to major histocompatibility complex molecules in the medullary thymic epithelial cells (TECs) [
17]. Estrogen also can modulate the development and differentiation of T-cells and the immune functions of the TECs, which are involved in autoimmunity via ERs [
18].
During the proestrus phase in the mouse thymus, a high level of estradiol decreases the percentage of CD4
+CD8
+ double-positive T cells via ERα, but in the proestrus phase, CD4
+CD8
- or CD4
-CD8
+ single positive T cells are significantly enhanced [
19]. In addition, during the first half of pregnancy, estriol is implicated in regulating the processes of myeloid dendritic cell maturation in the thymus and is also related to steroid-induced involution of the thymus [
20]. There is an upregulation of estrogen levels during pregnancy, which suppresses thymocyte proliferation and leads to thymic involution during pregnancy in mice [
21]. Our data revealed that mRNA and protein levels of ERα and ERβ upregulated at P13, but there was a downregulation of ERα and ERβ levels at P25. Thus, it is supposed that estrogens have effects on thymic function via ERα and ERβ in an endocrine manner during early pregnancy in sheep.
The lymph node consists of antigen-presenting cells and antigen-responsive cells, which are involved in the recruitment of naïve lymphocytes and antigen-presenting cells, the generation of adaptive immune responses, and the suppression of autoreactive cells [
22]. The presence of an embryo changes the function of the lymph nodes around the reproductive tract, which is implicated in regulating immune responses in the maternal local immune tissues during early pregnancy in the ovine [
23]. It has been reported that prostaglandin synthases, T helper cell cytokines, nod-like receptors, toll-like receptors, complement components, as well as nuclear factor kappa B family are modulated in ovine lymph nodes [
24], which is related to the maternal immune regulation in ewes. ERα is expressed by the follicular dendritic cells in lymph nodes, which is related to breast cancer and inflammation in humans [
25]. Our data manifested that the expression level of ERα peaked at P13 and P16, and the level of ERβ peaked only at P16. However, the expression levels of ERα and ERβ downregulated at P25. Therefore, ERα and ERβ are involved in the immunoregulation of maternal lymph nodes during early pregnancy, which is in an endocrine manner in ewes.
The spleen comprises the red and white pulp (WP), and the WP is the primary immunologic region, and the red pulp (RP) has an immune function distinct from the WP. The marginal zone (MZ) is between the WP and RP, and there are many macrophages in MZ [
26]. Estrogen has effects on the expression of some cytokines in the spleen dendritic cells from the female mice, which is through ERα [
27]. 17β-estradiol can regulate the function of mice spleen B cells, which is via toll-like receptor 9 [
28]. In addition, 17β-estradiol has beneficial effects on the function of splenic CD4
+ T lymphocytes, which is mediated by ERα, but not ERβ, and related to the suppression of endoplasmic reticulum stress [
29]. Early pregnancy increases the level of ERα and the percentage of mature macrophages in the spleen of female mice, which plays a cardinal role in regulating immune phenomena during pregnancy [
30]. It has been reported that early pregnancy has effects on the expression of T helper cell cytokines, toll-like receptors, and nuclear factor kappa B family in the ovine spleen [
24,
31], which is implicated in the maternal immune adaptation. Our results revealed that early pregnancy enhanced the expression of ERα and ERβ. Therefore, the upregulation of ERα and ERβ is implicated in modulating maternal splenic function during early pregnancy through an endocrine manner.
As the largest gland of the body, the liver plays cardinal roles in immunologic responses and nutrient metabolism, and there are necessary hepatic adaptations in immunology and nutrition during normal pregnancy [
32].
ERα mRNA level in the liver is enhanced from day 7 to 21 of pregnancy, and the expression level of
ERβ is variable during pregnancy, which is related to hepatic synthetic functions in rats [
33]. Estrogen can change the cytokine/chemokine repertoire in the liver via ERs, which are involved in modulating the liver immunosuppressive microenvironment [
34]. 17β-estradiol supplementation can improve mitochondrial function to prevent nonalcoholic fatty liver disease via the ERα pathway in bilateral oophorectomy female rats [
35]. The previous reports show that early pregnancy modulates the expression of Th cytokines, toll-like receptor pathway, nuclear factor kappa B signaling, complement components, nod-like receptors, and CD4, which is associated with the hepatic local immunosuppressive milieu in sheep [
32]. Our results showed that early pregnancy suppressed the expression of ERα and ERβ, but there were increases in expression levels of ERα and ERβ from P13 to P25. Therefore, the changes in the expression of hepatic ERα and ERβ are involved in regulating maternal hepatic function, including the immune function, during early pregnancy.
It has been reported that pregnancy has effects on estrogen levels [
21], which may modulate the expression of ERα and ERβ in the maternal thymus, lymph nodes, spleen, and liver via an endocrine manner. Therefore, estrogen exerts its actions on these maternal immune organs via ERα and ERβ in a tissue-specific manner to regulate maternal immune function during early pregnancy (
Figure 5).
Author Contributions
Conceptualization, L.Y.; methodology, Z.Y., Y.Z., Z.C.; validation, Z.L.; investigation, Z.Y., Y.Z., Z.C.; data curation, Z.L.; writing—original draft preparation, L.Y.; writing—review and editing, L.Z.; visualization, L.Z.; supervision, L.Y.; project administration, L.Z.; funding acquisition, L.Y. All authors have read and agreed to the published version of the manuscript.